Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Eosinophils downregulate lung alloimmunity by decreasing TCR signal transduction
Onyema, Oscar Okwudiri , Guo, Yizhan , Mahgoub, Bayan , Wang, Qing , Manafi, Amir , Mei, Zhongcheng , Banerjee, Anirban , Li, Dongge , Stoler, Mark H. , Zaidi, Melissa T. , Schrum, Adam G. , Kreisel, Daniel , Jacobsen, Elizabeth A. , Krupnick, Alexander S. , Schrum, Adam G , Jacobsen, Elizabeth A , Gelman, Andrew E

Mayo Clinic

JCI Insight | June 5, 2019 | Volume: 4 | Issue: 11 | Pages: No page available

10.1172/jci.insight.128241 | PMID 31167966 Get It

Despite the accepted notion that granulocytes play a universally destructive role in organ and tissue grafts, it has been recently described that eosinophils can facilitate immunosuppression-mediated acceptance of murine lung allografts. The mechanism of eosinophil-mediated tolerance, or their role in regulating alloimmune responses in the absence of immunosuppression, remains unknown. Using lung transplants in a fully MHC-mismatched BALB/c (H2 d ) to C57BL/6 (H2 b ) strain combination, we demonstrate that eosinophils downregulate T cell–mediated immune responses and play a tolerogenic role even in the absence of immunosuppression. We further show that such downregulation depends on PD-L1/PD-1–mediated synapse formation between eosinophils and T cells. We also demonstrate that eosinophils suppress T lymphocyte responses through the inhibition of T cell receptor/CD3 (TCR/CD3) subunit association and signal transduction in an inducible NOS–dependent manner. Increasing local eosinophil concentration, through administration of intratracheal eotaxin and IL-5, can ameliorate alloimmune responses in the lung allograft. Thus, our data indicate that eosinophil mobilization may be utilized as a novel means of lung allograft–specific immunosuppression.
A Systematic Review and Network Meta-Analysis of Regorafenib and TAS-102 in Refractory Metastatic Colorectal Cancer
Sonbol, Mohamad Bassam , Benkhadra, Raed, Firwana, Belal , Walden, Daniel J., Mody, Kabir , Murad, M. Hassan , Ahn, Daniel H. , Bekaii‐Saab, Tanios , Walden, Daniel , Hubbard, Joleen M. , Murad, M Hassan , Sonbol, Mohamad B , Bekaii-Saab, Tanios S , Wang, Zhen

Mayo Clinic

The Oncologist | June 4, 2019 | Volume: 24 | Issue: 9 | Pages: 1174-1179

10.1634/theoncologist.2019-0189 | PMID 31164455 Get It

Abstract Background Regorafenib at different dosing strategies and TAS-102 are treatment options for refractory metastatic colorectal cancer (mCRC). We aimed to evaluate the comparative effectiveness evidence supporting these different strategies. Materials and Methods We searched different databases for randomized controlled trials evaluating TAS-102 or regorafenib in patients with refractory mCRC who failed prior oxaliplatin, irinotecan, and fluoropyrimidine. Outcomes of interest included overall survival (OS) and progression-free survival (PFS). The overall effect was pooled using the DerSimonian random effects model. We conducted network meta-analysis based on White's multivariate meta-regression to pool evidence from direct and indirect comparisons. Results Six trials at low risk of bias (2,445 patients) were included. Direct comparisons showed that Rego 160 and TAS-102 as monotherapy were superior to best-supportive care (BSC) in terms of PFS (Rego 160: hazard ratio [HR], 0.4; 95% confidence ratio [CI], 0.26–0.63; TAS-102: HR, 0.46 CI, 0.40–0.52) and OS (Rego 160: HR, 0.67; CI, 0.48–0.93; TAS-102: HR, 0.67; CI, 0.57–0.80). Network analysis showed no statistically difference in PFS or OS between Rego 160 and TAS-102. Rego 80+ was superior to BSC in terms of OS (HR, 0.44; CI, 0.23–0.84) and PFS (HR, 0.37; CI, 0.21–0.66). Rego 80+ was associated with statistically nonsignificant improvement in OS and PFS compared with TAS-102 and Rego 160. Conclusion Regorafenib 160 and TAS-102 appear to have similar efficacy. Rego 80+ is shown to be superior to BSC. A trend for improved OS was observed with Rego 80+ versus Rego 160 or TAS 102. Implications for Practice Regorafenib at a dose of 160 mg and TAS-102 appear to have similar efficacy in patients with refractory metastatic colorectal cancer. Regorafenib with a dose escalation strategy is superior to best-supportive care. Given its tolerability and the observed trend in survival benefit compared with regorafenib 160, dose escalation strategy of regorafenib (80+) may be the preferred option in this setting.
Test collections for electronic health record-based clinical information retrieval
Wang, Yanshan , Hersh, William , Liu, Sijia , Hersh, William , Wen, Andrew , Bedrick, Steven , Liu, Hongfang , Wang, Yanshan

Mayo Clinic

JAMIA Open | June 4, 2019 | Volume: 2 | Issue: 3 | Pages: 360-368

10.1093/jamiaopen/ooz016 | PMID 31709390 Get It

AbstractObjectivesTo create test collections for evaluating clinical information retrieval (IR) systems and advancing clinical IR research.Materials and MethodsElectronic health record (EHR) data, including structured and free-text data, from 45 000 patients who are a part of the Mayo Clinic Biobank cohort was retrieved from the clinical data warehouse. The clinical IR system indexed a total of 42 million free-text EHR documents. The search queries consisted of 56 topics developed through a collaboration between Mayo Clinic and Oregon Health & Science University. We described the creation of test collections, including a to-be-evaluated document pool using five retrieval models, and human assessment guidelines. We analyzed the relevance judgment results in terms of human agreement and time spent, and results of three levels of relevance, and reported performance of five retrieval models.ResultsThe two judges had a moderate overall agreement with a Kappa value of 0.49, spent a consistent amount of time judging the relevance, and were able to identify easy and difficult topics. The conventional retrieval model performed best on most topics while a concept-based retrieval model had better performance on the topics requiring conceptual level retrieval.DiscussionIR can provide an alternate approach to leveraging clinical narratives for patient information discovery as it is less dependent on semantics. Our study showed the feasibility of test collections along with a few challenges.ConclusionThe conventional test collections for evaluating the IR system show potential for successfully evaluating clinical IR systems with a few challenges to be investigated.
NT-proBNP, race and endothelial function in the Multi-Ethnic Study of Atherosclerosis
Yang, Sushan , Huang, Shi , Daniels, Lori B. , Cannone, Valentina , Burnett, John C. , Beckman, Joshua A. , Carr, J. Jeffrey , Wang, Thomas J. , Gupta, Deepak K. , Gupta, Deepak K , Daniels, Lori B , Yeboah, Joseph , Lima, João A.C. , Beckman, Joshua A

Mayo Clinic

Heart | May 31, 2019 | Volume: 105 | Issue: 20 | Pages: 1590-1596

10.1136/heartjnl-2019-314707 | PMID 31152069 Get It

Objective Natriuretic peptides (NPs) are hormones with cardioprotective effects. NP levels vary by race; however, the pathophysiological consequences of lower NP levels are not well understood. We aimed to quantify the association between NPs and endothelial function as measured by flow-mediated dilation (FMD) and the contribution of NP levels to racial differences in endothelial function. Methods In this cross-sectional study of 2938 Multi-Ethnic Study of Atherosclerosis participants (34% Caucasian, 20% African-American, 20% Asian-American and 26% Hispanic) without cardiovascular disease at baseline, multivariable linear regression models were used to examine the association between serum N-terminal pro-B-type NP (NT-proBNP) and natural log-transformed FMD. We also tested whether NT-proBNP mediated the relationship between race and FMD using the product of coefficients method. Results Among African-American and Chinese-American individuals, lower NT-proBNP levels were associated with lower FMD, β=0.06 (95% CI: 0.03 to 0.09; p<0.001) and β=0.06 (95% CI: 0.02 to 0.09; p=0.002), respectively. Non-significant associations between NT-proBNP and FMD were found in Hispanic and Caucasian individuals. In multivariable models, endothelial function differed by race, with African-American individuals having the lowest FMD compared with Caucasians, p<0.001. Racial differences in FMD among African-Americans and Chinese-Americans were mediated in part by NT-proBNP levels (African-Americans, mediation effect: −0.03(95% CI: −0.05 to −0.01); Chinese-Americans, mediation effect: −0.03(95% CI: −0.05 to −0.01)). Conclusions Lower NP levels are associated with worse endothelial function among African-Americans and Chinese-Americans. A relative NP deficiency in some racial/ethnic groups may contribute to differences in vascular function.
Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease
Liu, Huan , He, Jin , Koh, Su Pin , Zhong, Yuping , Liu, Zhiqiang , Wang, Zhi‐Qiang , Zhang, Yujin , Li, Zongwei , Tam, Bjorn T. , Xiao, Min , Starbuck, Michael W., Navone, Nora M. , Davis, R. Eric , Tong, Qiang , Bergsagel, P. Leif , Yi, Qing , Orlowski, Robert Z. , Yang, Jing , Bergsagel, P. Leif , Xiao, Min , Amini, Behrang , Navone, Nora M , Davis, Richard E , Tong, Qiang , Yi, Qing , Gagel, Robert F. , Yang, Jing , Orlowski, Robert Z. , Lin, Pei , Young, Ken H. , Lee, Hans C. , Hou, Jian , Liu, Zhiqiang

Mayo Clinic

Science Translational Medicine | May 29, 2019 | Volume: 11 | Issue: 494 | Pages: No page available

10.1126/scitranslmed.aau9087 | PMID 31142679 Get It

Marrow adipocytes reprogrammed by myeloma cells induce bone lesions.
Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing
Wang, Liwei , Jiang, Min , Nian, Hui , Du, Xianglin L. , Denny, Joshua C. , Xu, Hua , Denny, Joshua C , Wu, Yonghui , Warner, Jeremy L. , Xu, Jun , Chen, Qingxia , Dai, Qi Chang , Yang, Ping , Liu, Hongfang

Mayo Clinic

JCO Clinical Cancer Informatics | May 29, 2019 | Volume: No volume available | Issue: 3 | Pages: 1-9

10.1200/cci.19.00001 | PMID 31141421 Get It

PURPOSEDrug development is becoming increasingly expensive and time consuming. Drug repurposing is one potential solution to accelerate drug discovery. However, limited research exists on the use of electronic health record (EHR) data for drug repurposing, and most published studies have been conducted in a hypothesis-driven manner that requires a predefined hypothesis about drugs and new indications. Whether EHRs can be used to detect drug repurposing signals is not clear. We want to demonstrate the feasibility of mining large, longitudinal EHRs for drug repurposing by detecting candidate noncancer drugs that can potentially be used for the treatment of cancer.PATIENTS AND METHODSBy linking cancer registry data to EHRs, we identified 43,310 patients with cancer treated at Vanderbilt University Medical Center (VUMC) and 98,366 treated at the Mayo Clinic. We assessed the effect of 146 noncancer drugs on cancer survival using VUMC EHR data and sought to replicate significant associations (false discovery rate < .1) using the identical approach with Mayo Clinic EHR data. To evaluate replicated signals further, we reviewed the biomedical literature and clinical trials on cancers for corroborating evidence.RESULTSWe identified 22 drugs from six drug classes (statins, proton pump inhibitors, angiotensin-converting enzyme inhibitors, β-blockers, nonsteroidal anti-inflammatory drugs, and α-1 blockers) associated with improved overall cancer survival (false discovery rate < .1) from VUMC; nine of the 22 drug associations were replicated at the Mayo Clinic. Literature and cancer clinical trial evaluations also showed very strong evidence to support the repurposing signals from EHRs.CONCLUSIONMining of EHRs for drug exposure–mediated survival signals is feasible and identifies potential candidates for antineoplastic repurposing. This study sets up a new model of mining EHRs for drug repurposing signals.
Platelet-Rich Emboli in Cerebral Large Vessel Occlusion Are Associated With a Large Artery Atherosclerosis Source
Wang, Shunli , Douglas, Andrew , Kadirvel, Ramanathan , Thacker, Ike, Gounis, Matthew J. , Chueh, Ju-Yu , Puri, Ajit S , Sauvageau, Eric , Aghaebrahim, Amin, Kvamme, Peter , Kallmes, David F. , Doyle, Karen , Brinjikji, Waleed , Fitzgerald, Seán , Dai, Daying , Layton, Kennith F. , Almekhlafi, Mohammed , Demchuk, Andrew M. , Hanel, Ricardó A. , Yoo, Albert J. , Mendes Pereira, Vitor , Kayan, Yasha , Almandoz, Josser E Delgado , Nogueira, Raul G. , Rabinstein, Alejandro A.

Mayo Clinic

Stroke | May 29, 2019 | Volume: 50 | Issue: 7 | Pages: 1907-1910

10.1161/strokeaha.118.024543 | PMID 31138084 Get It

Background and Purpose— Nearly 30% of large vessel occlusion acute ischemic stroke clots are from an unknown source. We assessed histological clot composition in a series of patients with large vessel occlusion and investigated correlations between clot composition and stroke pathogenesis. Methods— As part of the multi-institutional STRIP registry (Stroke Thromboembolism Registry of Imaging and Pathology), consecutive emboli retrieved during mechanical thrombectomy were stained using Martius Scarlett Blue and analyzed using machine learning software. We assessed proportions of red blood cells, fibrin, platelets, and white blood cells. Correlations between clot components and stroke pathogenesis (large artery atherosclerosis, cardioembolism, and stroke of undetermined pathogenesis) were assessed using SPSS22. Results— One hundred five patients were included. The proportion of platelet-rich clots (55.0% versus 21.2%; P =0.005) and percentage of platelet content (22.1±4.2% versus 13.9±14.2%; P =0.03) was significantly higher in the large artery atherosclerosis group compared with the cardioembolic group. The proportion of platelet-rich clots (50.0% versus 21.2%; P =0.024) was also significantly higher in the cryptogenic group compared with cardioembolic cases. Large artery atherosclerosis and cryptogenic cases had a similar proportion of platelet-rich clots (55.0% versus 50.0%; P =0.636). There was no significant difference between stroke pathogenesis and the other major clot components. Conclusions— High platelet content of emboli is associated with a large artery atherosclerosis etiology of large vessel occlusion.
Identification of Apnea Events Using a Chest-Worn Monitor Compared to Laboratory-Based Polysomnography in Patients Suspected of Obstructive Sleep Apnea
Toledo, Meynard John L. , Parish, James M., Salazar, Eduardo, Gupta, Mayank , Wang, Qiao , Turaga, Pavan K. , Buman, Matthew P.

Mayo Clinic

Journal for the Measurement of Physical Behaviour | May 29, 2019 | Volume: 2 | Issue: 2 | Pages: 103-108

10.1123/jmpb.2018-0013 Get It